pooled analysis · 2013
“The limited trial evidence to date synthesised in this review does not support the use of selenium supplements in the primary prevention of cardiovascular disease.”
Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev
Who: adults from the general population and at high risk of CVD; mostly men from the selenium-replete US (SELECT and NPC), with over 96% of participants from US-based studies
PMID 23440843
controlled trial · 2009 · landmark
“In this trial, neither 200 µg of selenomethionine or 400 IU of synthetic DL of alpha-tocopherol, given orally alone or combined for a median of 5.5 years had significant effects on the primary or secondary endpoints.”
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA
Who: 35,533 relatively healthy men aged 50+ (African American) or 55+ (others) with PSA <=4 ng/mL and a non-suspicious DRE, in the US, Canada and Puerto Rico; described as well-nourished at baseline
PMID 19066370
controlled trial · 2011 · landmark
“The lack of benefit from dietary supplementation with vitamin E or other agents with respect to preventing common health conditions and cancers or improving overall survival, and their potential harm, underscore the need for consumers to be skeptical of health claims for unregulated over-the-counter products in the absence of strong evidence of benefit from clinical trials.”
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA
Who: Relatively healthy men aged 50+ (African American) or 55+ (all others) with PSA <=4.0 ng/mL and a non-suspicious digital rectal exam, at 427 sites in the US, Canada and Puerto Rico; supplements given on top of a normal diet
PMID 21990298
controlled trial · 2009 · landmark
“In this large-scale, randomized controlled trial among middle-aged and older men, neither long-term vitamin E nor vitamin C supplementation reduced the risk of prostate or total cancer.”
Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA
Who: US male physicians aged >=50 years (mean age 64.3), a well-nourished population, including 1,307 men with a prior cancer at randomization
PMID 19066368